BioSpace News Archive

BioTime, Inc., a late-stage, clinical biotechnology company developing and commercializing products addressing degenerative diseases, today announced the appointment of Gary S. Hogge, DVM, MS, PhD, as Sr. Vice President, Clinical and Medical Affairs, a newly created position.

East River Imaging Brings State of the Art Imaging to Patients in New York with LabFinder.com

Noninvasive test is changing how Americans get checked for the most preventable form of cancer.

Will highlight various innovative analytical systems and new high-value solutions for food analysis, pharmaceutical, clinical research, and materials science applications.

“The patient recruitment in the CONDUCT study is developing as expected and our objective to report top line results from the study in the fourth quarter of 2018 remains,” said Peter Zerhouni, CEO of InDex Pharmaceuticals.

This partnership expands Edico Genome’s existing agreements with leading tertiary analysis providers and leverages the world-class healthcare IT solutions and expertise of InterSystems to allow physicians to easily order a genomic test at point of care and enable comprehensive data analysis through seamless exchange of clinical and genomic information across the entire patient electronic medical record.

Expanded Partnership Leverages Selexis’ Expertise in Recombinant Therapeutic Development Solutions

DUR-928 is an endogenous, first-in-class small molecule, which may have broad applicability in several hepatic and renal diseases such as nonalcoholic steatohepatitis (NASH) and other disorders of the liver such as PSC, in acute organ injuries such as acute liver and kidney injury, and in inflammatory skin disorders such as psoriasis and atopic dermatitis.

New system will include smartphone-enabled sales and distribution system connecting medicinal cannabis patients with local dispensary drivers for fast delivery and monitoring of orders.

Financing to Further Support Growth of MRIdian Linac